MidLantic Urology ( Site 0102) — Bala-Cynwyd, Pennsylvania

MidLantic Urology ( Site 0102) is a clinical research site located in Bala-Cynwyd, Pennsylvania, United States 19004.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

MidLantic Urology ( Site 0102) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidLantic Urology ( Site 0102)?

MidLantic Urology ( Site 0102) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidLantic Urology ( Site 0102) conducted?

MidLantic Urology ( Site 0102) has 1 clinical trials on record, with 1 currently active. Their work covers Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ.

Is MidLantic Urology ( Site 0102) accredited by Crixeo Health?

MidLantic Urology ( Site 0102) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidLantic Urology ( Site 0102)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.